{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:22:18Z","timestamp":1770067338165,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.nano.2019.102091","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T20:05:33Z","timestamp":1571169933000},"page":"102091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system"],"prefix":"10.1016","volume":"22","author":[{"given":"Yingfang","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harkiranpreet Kaur","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archita Venugopal","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JuOae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor M.","family":"Amiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonghan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.nano.2019.102091_bb0005","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis\u2014a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(99)70244-1","article-title":"Molecular medicine and hemochromatosis: at the crossroads","volume":"116","author":"Bacon","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.nano.2019.102091_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment","volume":"139","author":"Pietrangelo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2019.102091_bb0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1196\/annals.1345.047","article-title":"Physiology and pathophysiology of iron cardiomyopathy in thalassemia","volume":"1054","author":"Wood","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.nano.2019.102091_bb0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1600-0609.2009.01228.x","article-title":"Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study","volume":"82","author":"Taher","year":"2009","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.nano.2019.102091_bb0030","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood.V78.10.2727.2727","article-title":"Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded mice","volume":"78","author":"Porter","year":"1991","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.nano.2019.102091_bb0035","first-page":"1077","article-title":"Acute changes in renal function associated with deferoxamine therapy","volume":"143","author":"Koren","year":"1989","journal-title":"Am J Dis Child"},{"issue":"7","key":"10.1016\/j.nano.2019.102091_bb0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199808133390701","article-title":"Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major","volume":"339","author":"Olivieri","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.nano.2019.102091_bb0045","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrneph.2014.121","article-title":"Deferasirox nephrotoxicity\u2014the knowns and unknowns","volume":"10","author":"Diaz-Garcia","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.nano.2019.102091_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/BJ20061290","article-title":"Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1)","volume":"403","author":"Mackenzie","year":"2007","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4067\/S0716-97602006000100009","article-title":"DMT1: which metals does it transport?","volume":"39","author":"Garrick","year":"2006","journal-title":"Biol Res"},{"issue":"6641","key":"10.1016\/j.nano.2019.102091_bb0065","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/41343","article-title":"Cloning and characterization of a mammalian proton-coupled metal-ion transporter","volume":"388","author":"Gunshin","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.nano.2019.102091_bb0070","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.96.6.3143","article-title":"Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1","volume":"96","author":"Fleming","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.nano.2019.102091_bb0075","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1053\/gast.2001.24050","article-title":"Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis","volume":"120","author":"Griffiths","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.nano.2019.102091_bb0080","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1053\/gast.2001.24033","article-title":"Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload","volume":"120","author":"Zoller","year":"2001","journal-title":"Gastroenterology"},{"issue":"26","key":"10.1016\/j.nano.2019.102091_bb0085","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.nano.2019.102091_bb0090","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI24356","article-title":"Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver","volume":"115","author":"Gunshin","year":"2005","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.nano.2019.102091_bb0095","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.chembiol.2006.08.005","article-title":"Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake","volume":"13","author":"Wetli","year":"2006","journal-title":"Chem Biol"},{"issue":"3","key":"10.1016\/j.nano.2019.102091_bb0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuint.2012.05.016","article-title":"Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake","volume":"61","author":"Xie","year":"2012","journal-title":"Neurochem Int"},{"issue":"15","key":"10.1016\/j.nano.2019.102091_bb0105","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1016\/j.bmcl.2012.05.129","article-title":"Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors","volume":"22","author":"Zhang","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bmcl.2011.11.069","article-title":"Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1)","volume":"22","author":"Cadieux","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"American Association for the Study of Liver Diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.nano.2019.102091_bb0120","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.83.12.4552","article-title":"Retroviral transfer of genes into canine hemopoietic progenitor cells in culture: a model for human gene therapy","volume":"83","author":"Kwok","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11\u201312","key":"10.1016\/j.nano.2019.102091_bb0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.drudis.2008.03.014","article-title":"Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?","volume":"13","author":"Rayburn","year":"2008","journal-title":"Drug Discov Today"},{"issue":"5","key":"10.1016\/j.nano.2019.102091_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat Rev Genet"},{"issue":"7","key":"10.1016\/j.nano.2019.102091_bb0135","first-page":"1143","article-title":"Therapeutic targeting in the silent era: advances in non-viral siRNA delivery","volume":"6","author":"Guo","year":"2010","journal-title":"Mol Biosyst"},{"issue":"16","key":"10.1016\/j.nano.2019.102091_bb0140","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s40265-014-0297-2","article-title":"Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations","volume":"74","author":"Liu","year":"2014","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.1997.15.1.110","article-title":"Patient preferences for oral versus intravenous palliative chemotherapy","volume":"15","author":"Liu","year":"1997","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.nano.2019.102091_bb0150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jconrel.2012.06.037","article-title":"Oral delivery of small RNA and DNA","volume":"162","author":"Forbes","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102091_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2013.10.001","article-title":"Drug delivery strategies in the therapy of inflammatory bowel disease","volume":"71","author":"Lautenschlager","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.nano.2019.102091_bb0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.addr.2012.11.003","article-title":"Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract","volume":"65","author":"Kriegel","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.nano.2019.102091_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1478","article-title":"Oral nucleic acid therapy using multicompartmental delivery systems","volume":"10","author":"Attarwala","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"3","key":"10.1016\/j.nano.2019.102091_bb0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2007.03.006","article-title":"Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS)","volume":"119","author":"Bhavsar","year":"2007","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2019.102091_bb0175","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2005.11.001","article-title":"Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design","volume":"110","author":"Bhavsar","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102091_bb0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.colsurfb.2013.05.016","article-title":"pH-sensitive microparticles for oral drug delivery based on alginate\/oligochitosan\/Eudragit((R)) L100-55 \"sandwich\" polyelectrolyte complex","volume":"110","author":"Calija","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"10.1016\/j.nano.2019.102091_bb0185","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijpharm.2013.09.029","article-title":"Poly(meth)acrylate-based coatings","volume":"457","author":"Nollenberger","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2010.10.002","article-title":"Oral TNF-alpha gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease","volume":"150","author":"Kriegel","year":"2011","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/j.nano.2019.102091_bb0195","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/acs.molpharmaceut.7b00233","article-title":"Cosilencing intestinal transglutaminase-2 and interleukin-15 using gelatin-based nanoparticles in an in vitro model of celiac disease","volume":"14","author":"Attarwala","year":"2017","journal-title":"Mol Pharm"},{"issue":"13","key":"10.1016\/j.nano.2019.102091_bb0200","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.biomaterials.2013.01.077","article-title":"Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors","volume":"34","author":"Ganesh","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0205","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/bp9701271","article-title":"Development and scale-up of a microsphere protein delivery system","volume":"14","author":"Tracy","year":"1998","journal-title":"Biotechnol Prog"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jps.20216","article-title":"Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles","volume":"94","author":"Kaul","year":"2005","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.nano.2019.102091_bb0215","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acs.molpharmaceut.5b00575","article-title":"Efficient and Tumor targeted siRNA delivery by polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol)","volume":"13","author":"Liu","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2019.102091_bb0225","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Frohlich","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"10.1016\/j.nano.2019.102091_bb0230","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.nano.2019.102091_bb0235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1039\/c3mb70502a","article-title":"Protamine sulfate-calcium carbonate-plasmid DNA ternary nanoparticles for efficient gene delivery","volume":"10","author":"Wang","year":"2014","journal-title":"Mol Biosyst"},{"issue":"3","key":"10.1016\/j.nano.2019.102091_bb0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejpb.2009.02.013","article-title":"The use of Eudragit RS 100\/cyclodextrin nanoparticles for the transmucosal administration of glutathione","volume":"72","author":"Lopedota","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2004.09.019","article-title":"Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles","volume":"288","author":"Ubrich","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2019.102091_bb0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-8-127","article-title":"Housekeeping and tissue-specific genes in mouse tissues","volume":"8","author":"Kouadjo","year":"2007","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425247.2013.736962","article-title":"Eudragit: a technology evaluation","volume":"10","author":"Thakral","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.nano.2019.102091_bb0260","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mrm.10207","article-title":"Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance","volume":"48","author":"Schwarz","year":"2002","journal-title":"Magn Reson Med"},{"issue":"1","key":"10.1016\/j.nano.2019.102091_bb0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2191-219X-3-60","article-title":"Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT","volume":"3","author":"Padmanabhan","year":"2013","journal-title":"EJNMMI Res"},{"issue":"5","key":"10.1016\/j.nano.2019.102091_bb0270","doi-asserted-by":"crossref","first-page":"L887","DOI":"10.1152\/ajplung.00382.2004","article-title":"Pharmacokinetics of pulmonary manganese absorption: evidence for increased susceptibility to manganese loading in iron-deficient rats","volume":"288","author":"Heilig","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.nano.2019.102091_bb0275","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ymthe.2019.01.003","article-title":"Oral gavage of ginger nanoparticle-derived lipid vectors carrying Dmt1 siRNA blunts iron loading in murine hereditary hemochromatosis","volume":"27","author":"Wang","year":"2019","journal-title":"Mol Ther"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:09:57Z","timestamp":1761548997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419301753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":55,"alternative-id":["S1549963419301753"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2019.102091","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2019.102091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102091"}}